InsidersTradesSigma
Total declarations
Companies
▲ Purchases (11 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
11
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-40.4%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Armistice Capital, Llc. Director active across 7 companies, notably Aytu Biopharma, INC. Cumulatively, 19 disclosures have been logged. Split: 11 buys · 3 sells. Total volume traded: €5.1m. Activity tracked since 20 March 2021. The latest transaction was filed on 26 June 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Armistice Capital, Llc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
2,746,138 shares@ US$0.612554.8% of flowCommon StockSEC:0000899243-23-016659:0
334 shares@ US$3.950.0% of flowCommon StockSEC:0000899243-23-004412:0
26,000 shares@ US$0.7010.0049% mcap1.3% of flowCommon StockSEC:0000899243-22-010904:0
Canonical exit: 8 Jun 2022 (T+90)
50,000 shares@ US$0.71390.0096% mcap2.5% of flowCommon StockSEC:0000899243-22-009744:0
Canonical exit: 1 Jun 2022 (T+90)
100,000 shares@ US$0.80090.021% mcap5.6% of flowCommon StockSEC:0000899243-22-008145:0
Canonical exit: 25 May 2022 (T+90)
150,000 shares@ US$0.8150.032% mcap8.5% of flowCommon StockSEC:0000899243-22-007249:0
Canonical exit: 18 May 2022 (T+90)
206,300 shares@ US$0.88330.048% mcap12.6% of flowCommon StockSEC:0000899243-22-002693:0
Canonical exit: 18 Apr 2022 (T+90)
57,300 shares@ US$1.04330.016% mcap4.1% of flowCommon StockSEC:0000899243-22-002025:0
Canonical exit: 12 Apr 2022 (T+90)
137,900 shares@ US$1.03680.038% mcap10.0% of flowCommon StockSEC:0000899243-22-001618:0
Canonical exit: 7 Apr 2022 (T+90)
95,455 shares@ US$2.26238.0% of flowCommon StockSEC:0000899243-21-036402:0
Canonical exit: 14 Dec 2021 (T+90)
30,000 shares@ US$2.754613.4% of flowCommon StockSEC:0000899243-21-033505:0
Canonical exit: 14 Nov 2021 (T+90)
100,000 shares@ US$2.685943.2% of flowCommon StockSEC:0001567619-21-014631:0
Canonical exit: 2 Nov 2021 (T+90)
68,188 shares@ US$2.6924.3% of flowCommon StockSEC:0001567619-21-014361:0
852,500 shares@ US$4.8095.7% of flowCommon StockSEC:0000899243-21-030722:0
1,479,713 sharesCommon StockSEC:0000919574-21-004321:0
388,045 shares@ US$6.52100.0% of flowCommon StockSEC:0000919574-21-004191:0
5,330,277 sharesCommon StockSEC:0000919574-21-004187:0
128,000 shares@ US$2.1543.4% of flowCommon StockSEC:0000919574-21-003782:0
Canonical exit: 12 Aug 2021 (T+90)
6,959 shares0Common StockSEC:0000919574-21-003313:0
19 of 19 declarations
About Armistice Capital, Llc
ARMISTICE CAPITAL, LLC filed 19 filings in total. Across the 19 sampled recent filings, the activity runs from 2021-05-10 to 2023-06-28, with EUR 1,273,358 in purchases and EUR 3,805,144 in sales. The entity is listed as Director at Cerecor Inc. and Aytu Biopharma, INC.
